Loading clinical trials...
Loading clinical trials...
This study is conducted in Japan. The aim of this observational study is to collect information about the safety and efficacy of Norditropin® long-term treatment of growth hormone deficiency in adults...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Novo Nordisk A/S
NCT05230550 · Adult Growth Hormone Deficiency
NCT02616562 · Growth Hormone Disorder, Growth Hormone Deficiency in Children
NCT07259564 · Adult Growth Hormone Deficiency (AGHD)
NCT01909479 · Adult Growth Hormone Deficiency
NCT01514500 · Growth Hormone Disorder, Adult Growth Hormone Deficiency, and more
Tokyo
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions